Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
05/29/1990 | US4929467 Processes for products from lotus |
05/29/1990 | US4929444 Low pH pharmaceutical formulation containing t-PA |
05/29/1990 | US4929440 Process for the preparation of (-) eburnamenin-14-(15H)-one resinates |
05/29/1990 | CA1269618A1 Aqueous liquid preparation containing 2-amino-7-alkyl- 5-oxo-5h¬1|benzopyrano-¬2,3-b|pyridine-3- carboxylic acid |
05/23/1990 | EP0369816A2 Monoclonal antibodies specific for human polymorphic epithelial mucin |
05/23/1990 | EP0369608A1 Gel bases for pharmaceutical compositions |
05/23/1990 | EP0369516A2 Tailored beta-prime stable triglyceride hardstock |
05/23/1990 | EP0369515A1 Aqueous suspension for diagnostic tests |
05/23/1990 | EP0369463A2 Conjugate of prostaglandin and polysaccharide |
05/23/1990 | EP0369228A1 Effervescent Ibuprofen compositions |
05/23/1990 | EP0368933A1 Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloalkanes |
05/23/1990 | EP0368920A1 Lectines fixing beta-d-galactoside. |
05/23/1990 | EP0211946B1 Controlled release potassium chloride |
05/23/1990 | DE3839020A1 Fixierung von proteinen an festen traegern Fixation of proteins on solid supports |
05/23/1990 | DE3838900A1 Pyruvatkinase-isoenzym typ m2 (tumor m2-pk) spezifische antikoerper/verfahren zu deren herstellung und deren verwendung Pyruvate kinase isoenzyme type m2 (m2 tumor-pk) specific antibodies / process for their production and their use |
05/23/1990 | CA2003743A1 Polypeptide derivatives |
05/22/1990 | US4927860 Polyamide powder formed by particles having a gypsum rose structure and process for preparing such powder |
05/22/1990 | US4927640 Controlled release beads having glass or silicon dioxide core |
05/22/1990 | US4927638 Etoposide solutions |
05/22/1990 | US4927636 Sustained-release articles for consumer products, toiletries, cosmetics, pharmaceuticals and feeds |
05/22/1990 | US4927634 Pharmaceutical compositions containing dyclonine HC1 and phenol |
05/22/1990 | US4926869 Method for the diagnosis and treatment of inflammation |
05/22/1990 | CA2003595A1 Use of diorganopolysiloxanes as anti-oxidative agents in cosmetics and dermatology |
05/22/1990 | CA2003340A1 Pharmaceutical compositions |
05/22/1990 | CA1269328A1 Transdermal aqueous aryl-propionic-acid derivatives medication and methods of preparing same |
05/22/1990 | CA1269325A1 Osmotic device with self-sealing passageway |
05/22/1990 | CA1269205A1 Adsorption-resistant peptide composition |
05/18/1990 | CA2003273A1 Catalytic and reactive polypeptides and methods for their preparation and use |
05/18/1990 | CA2003272A1 Conjugated polypeptides and methods for their preparation and use |
05/18/1990 | CA2002965A1 Conjugate of prostaglandin and polysaccharide |
05/17/1990 | WO1990005157A1 Continuous process for manufacturing resorbable polyesters and their use |
05/17/1990 | WO1990004980A1 Drug composition |
05/17/1990 | WO1990004967A2 Topical ointment |
05/17/1990 | WO1990004965A1 Dosage form having reduced abuse potential |
05/17/1990 | WO1990004964A1 Pharmaceutical composition for ophthalmic use comprising a water soluble acid addition salt of ibopamine |
05/17/1990 | WO1990004963A1 Adhesive drug delivery composition |
05/17/1990 | CA2003211A1 Monoclonal antibodies |
05/16/1990 | EP0368682A1 Pharmaceutical ion exchange resin composition |
05/16/1990 | EP0368668A2 Antibody-drug conjugates |
05/16/1990 | EP0368449A2 Elastase inhibiting polymers and methods to produce them |
05/16/1990 | EP0368409A2 Compositions for the transdermal delivery of buprenorphine salts |
05/16/1990 | EP0368406A2 Compositions for the transdermal delivery of pharmaceutical actives |
05/16/1990 | EP0368339A2 Pharmaceutical preparation for percutaneous administration containing bunazosin or its salt |
05/16/1990 | EP0368253A2 Delivery system for pharmaceutical or therapeutic actives |
05/16/1990 | CN1042132A Precipitated silica absorbent, and compositions based on silica |
05/16/1990 | CN1042079A Methed and special apparatus for extracting gelatin |
05/16/1990 | CN1042076A Method for preparing anion exchange resin delivery system |
05/16/1990 | CN1042071A Novel dosage form |
05/16/1990 | CN1007958B Process for the preparation of metal complexes of bis-indole compounds and agueous pharmaceutical compositions containing them |
05/15/1990 | US4925922 Potentiation of cytotoxic conjugates |
05/15/1990 | US4925860 Anticonvulsants |
05/15/1990 | US4925736 Dispersed in carrier vehicle capable of deep penetration of mammalian skin |
05/15/1990 | US4925697 Process for products from sweet potato |
05/15/1990 | US4925696 Food substitutes; allergies |
05/15/1990 | US4925678 Endothelial envelopment drug carriers |
05/15/1990 | US4925677 Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents |
05/15/1990 | US4925673 Delivery systems for pharmacological agents encapsulated with proteinoids |
05/15/1990 | US4925666 Solubilized benzoyl peroxide and cosmetic solution including solubilized benzoyl peroxide |
05/15/1990 | US4925662 Antitumor agent bonded to human immunoglobulin |
05/15/1990 | US4925648 Two specific antibodies(or fragments) bound to imaging agents |
05/15/1990 | US4925033 Microbicidal cleanser/barrier kit |
05/14/1990 | CA2002860A1 Antibodies specific for elam-1 and the use thereof |
05/14/1990 | CA2002672A1 Aqueous suspension for diagnostic tests |
05/12/1990 | CA2002732A1 Effervescent ibuprofen preparations |
05/11/1990 | CA2002492A1 Pharmaceutical ion exchange resin composition |
05/11/1990 | CA2001574A1 Pharmaceutical preparation for percutaneous administration containing bunazosin or its salts |
05/10/1990 | DE3837304A1 Liquid sennoside product and process for its production |
05/10/1990 | CA2002299A1 Compositions for the transdermal delivery of buprenorphine salts |
05/10/1990 | CA2000483A1 Antibody-drug conjugates |
05/09/1990 | EP0367746A2 Sustained release drug-resin complexes |
05/09/1990 | EP0367586A1 Primycin solutions |
05/09/1990 | EP0367554A2 Insulin binders and inhibitors of insulin binding |
05/09/1990 | EP0367538A2 Stabilized phytic acid compositions |
05/09/1990 | EP0367489A2 Thromboresistant materials and methods for making same |
05/09/1990 | EP0367431A1 Novel composition for skin penetration enhancement |
05/09/1990 | EP0367362A2 Chemically modified hydrophilic prepolymers and polymers |
05/09/1990 | EP0367166A1 Modified interleukin-2 and production thereof |
05/09/1990 | EP0367103A1 Topical ointment |
05/09/1990 | EP0367056A2 A granulating composition and method |
05/09/1990 | EP0366990A2 Stable parenteral solution of 2-phenyl-1.2-benzisoselenazol-3(2H)-one and process for producing the same |
05/09/1990 | CN1041879A Preparation of pharmaceutical composition for preventing transmissible disease |
05/09/1990 | CA2002642A1 Stabilized aqueous leucovorin calcium compositions |
05/08/1990 | US4923976 Process for preparing surface-active glycosides and the use of the glycosides in cosmetic, pharmaceutical and household products |
05/08/1990 | US4923961 Process for deodorizing isobutylene polymer |
05/08/1990 | US4923900 Therapeutic compositions containing benzoyl peroxide |
05/08/1990 | US4923893 Skin protection; tocopheryl acetate, glycerhetinic acid, ethyl acrylate-methacrylic acid copolymer |
05/08/1990 | US4923876 Vincristine sulfate, citrate buffer |
05/08/1990 | US4923862 Topical preparation containing ofloxacin |
05/08/1990 | US4923854 Solubilization of hydrophobic materials using lysophospholipid |
05/08/1990 | US4923709 Foods; allergies |
05/08/1990 | CA2002404A1 Delivery system for pharmaceutical or therapeutic actives |
05/04/1990 | CA2002188A1 Composition containing an extract obtained by a water-containing organic solvent, and a process for preparing the same |
05/03/1990 | WO1990004606A1 A process for fractionating polyethylene glycol (peg)-protein adducts and an adduct of peg and granulocyte-macrophage colony stimulating factor |
05/03/1990 | WO1990004417A1 Methods of and compositions for diagnosing, monitoring and treating the early stages of osteoarthritis |
05/03/1990 | WO1990004414A1 Conjugates of soluble t4 proteins and toxins and methods for treating or preventing aids, arc and hiv infection |
05/03/1990 | WO1990004410A1 A novel family of high affinity, modified antibodies for cancer treatment |
05/03/1990 | WO1990004405A1 Antiviral agent |
05/03/1990 | WO1990004384A1 Liposomes |
05/03/1990 | DE3836863A1 Liquid, dissolved antirheumatic pharmaceutical preparations |
05/03/1990 | DE3836519A1 Pharmaceutical composition based on Calendula officinalis |